NEULANDLABNSENeuland Laboratories Limited· PharmaceuticalsMinimalNeutral
Announced Fri, 2 Jan · 17:42 IST

Neuland Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

NEULANDLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Neuland Laboratories has submitted a regulatory compliance certificate to BSE and NSE under SEBI's Depositories Regulations for the quarter ended December 31, 2025. The certificate, issued by their Registrar and Share Transfer Agent Kfin Technologies Limited, confirms that details of all securities dematerialized and rematerialized during the quarter have been duly reported to both depositories (NSDL and CDSL) and the stock exchanges. Separate confirmations have been filed with both CDSL and NSDL, addressed to the relevant authorities. This is a routine quarterly submission with no financial figures or business disclosures included.

Likely market impact

This is a standard procedural compliance filing with no material impact on the company's financials, operations, or stock price. It simply fulfils a recurring SEBI requirement to report share dematerialization/rematerialization activity each quarter.